Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2Unknown 1No longer available 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Neoplasms 4Breast Neoplasms 4Liver Neoplasms 2Esophageal Neoplasms 2Stage IA Uterine Sarcoma 1Prostate Cancer With Intermediate Risk 1Glioblastoma 1Endometrial Adenocarcinoma 1Deglutition Disorders 1Cholangiocarcinoma 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Carcinoma In Situ 1Brain Neoplasms 1

Interventions

Sorafenib 12Radiosurgery 5Gemcitabine 5Capecitabine 5Bevacizumab 5Radiotherapy 4Fluorouracil 4Doxorubicin 4Sunitinib 3Oxaliplatin 3Nivolumab 3Magnetic Resonance Spectroscopy 3seocalcitol 2regorafenib 2phosphomannopentaose sulfate 2atezolizumab 2Thiotepa 2Radiofrequency Ablation 2Melphalan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Fluorodeoxyglucose F18 2Filgrastim 2Dexamethasone 2Cisplatin 2Chemoembolization, Therapeutic 2Carboplatin 2Busulfan 2Brachytherapy 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Liver Neoplasms × Brachytherapy × Clear all
NCT02893982 2021-05-18

High Dose Rate Brachyablation of Primary Liver Lesions

University of Texas Southwestern Medical Center

Phase 1 Terminated
1 enrolled
Gastrointestinal

Liver Neoplasms

NCT00983541 2015-08-19

Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma

University of Utah

Phase 2 Terminated
1 enrolled 4 charts
Gastrointestinal

Liver Neoplasms, Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡